https://topotecaninhibitor.com..../the-allocated-quant
OBJECTIVE This study aimed to investigate the efficacy and protection of transcatheter arterial chemoembolization (TACE) utilizing CalliSpheres beads loading with arsenic trioxide (ATO) (CBATO) in unresectable hepatocellular carcinoma (HCC) patients. PATIENTS AND METHODS Eighty-six unresectable HCC patients going to receive TACE with CBATO or conventional TACE (cTACE) with ATO were consecutively enrolled and divided into CBATO group (N=38) or cTACE group (N=48), respectively. Treatment
Like
Comment
Share
